HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dravet syndrome: A quick transition guide for the adult neurologist.

AbstractINTRODUCTION:
Dravet syndrome (DS) is still seen as a "pediatric disease", where patients receive excellent care in pediatric centers, but care is less than optimal in adult health care systems (HCS). This creates a barrier when young adults need to leave the family-centered pediatric system and enter the adult, patient-centered HCS. Here we create a guide to help with the transition from pediatric to adult for patients with DS.
METHODS:
Experts in Dravet syndrome flagged the main barriers in caring for adults with DS and created a 2-page transition summary guide based on their expertise and a literature review.
RESULTS:
The 2-page guide addresses: DS diagnosis in children and adults; clinical manifestations, including the differences in seizures types and frequencies between children and adults with DS; the natural history of intellectual disability, behavior, gait, motor disorders and dysautonomia; a review of optimal treatments (including medications not commonly used in adult epilepsy settings such as stiripentol and fenfluramine), as well as emergency seizure management; avoidance of triggers, preventive measures, and vaccine administration in adults with DS.
CONCLUSION:
Several young adults with DS are still followed by their child neurologist. This 2-page transition guide should help facilitate the transition of patients with DS to the adult HCS and should be given to families as well as adult health care providers that may not be familiar with DS.
AuthorsDanielle M Andrade, Anne T Berg, Veronica Hood, Kelly G Knupp, Sookyong Koh, Linda Laux, Mary Anne Meskis, Ian Miller, M Scott Perry, Ingrid E Scheffer, Joseph Sullivan, Nicole Villas, Elaine Wirrell
JournalEpilepsy research (Epilepsy Res) Vol. 177 Pg. 106743 (Nov 2021) ISSN: 1872-6844 [Electronic] Netherlands
PMID34624600 (Publication Type: Journal Article, Review)
CopyrightCopyright © 2021 The Authors. Published by Elsevier B.V. All rights reserved.
Chemical References
  • Anticonvulsants
  • Fenfluramine
Topics
  • Anticonvulsants (therapeutic use)
  • Child
  • Epilepsies, Myoclonic (drug therapy, therapy)
  • Fenfluramine (therapeutic use)
  • Humans
  • Neurologists
  • Spasms, Infantile (drug therapy)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: